1
Supplemental
Supplementary Table 1. Variables included in optimized models Model type Included variables All subtypes (N=384, pCR rate = 114/384, 29.7%) FTV only Subtype, %FTV0_1, %FTV0_2
SPH only Subtype, SPH0
BPE only Subtype, BPE0, %BPE0_1, %BPE0_3
LD only Subtype, LD0, %LD0_2, %LD0_3 Combined Subtype, %FTV0_2, %SPH0_2, BPE0, %LD0_2, %LD0_3 HR+/HER2- (N=162, pCR rate = 24/162, 14.8%)
FTV only %FTV0_1, %FTV0_2, %FTV0_3
SPH only %SPH0_1, %SPH0_2 BPE only BPE0, %BPE0_1, %BPE0_3
LD only %LD0_2, %LD0_3
Combined %FTV0_1, %FTV0_3, %SPH0_1, BPE0, %BPE0_2, LD0, %LD0_2 HR+/HER2+ (N=60, pCR rate = 19/60, 31.7%) FTV only %FTV0_1, %FTV0_3
SPH only %SPH0_1
BPE only %BPE0_3 LD only %LD0_1, %LD0_3
Combined %SPH0_2, %BPE0_3, %LD0_3
HR-/HER2+ (N=30, pCR rate = 20/30, 66.7%) FTV only %FTV0_3
SPH only SPH0, %SPH0_1
BPE only BPE0, %BPE0_1, %BPE0_2
LD only LD0, %LD0_2
Combined %FTV0_3, SPH0, %SPH0_1, %BPE0_1
HR-/HER2- (triple negative, N=132, pCR rate = 51/132, 38.6%) FTV only %FTV0_1, %FTV0_2
SPH only %SPH0_1
BPE only BPE0, %BPE0_2
LD only %LD0_2
Combined %FTV0_2, %SPH0_2, BPE0, %BPE0_2, %LD0_2
*bolded AUCs were the highest AUC in each cohort. Bolded variables were with p<0.05.


2
Supplementary Table 2. Standardized I-SPY 2 DCE-MRI acquisition parameters
Parameter Value
Sequence type Gradient echo (GE) 2D or 3D sequence 3D Slice orientation Axial Laterality Bilateral Frequency direction A/P Phase direction R/L FOV - frequency 260 – 360 mm FOV - phase 260 – 360 mm Matrix – frequency (acquired)
384 – 512
In-plane resolution  1.4 mm Fat-suppression Active fat-sat recommended TR 4 – 10 ms TE Minimum TE Flit angle 10 – 20 degrees B values N/A Slice thickness (acquired, not interpoloated)
 2.5 mm
Number of slices  60; complete bilateral coverage Slice Gap No gap Parallel imaging factor  2 No. of excitations or averages
2
k-space ordering -k to +k (standard, non-centric) Sequence acquisition time 80 sec  scan time  100 sec Total post-contrast imaging duration
 8 minutes following injection


3
Supplementary Figure 1. Illustration of MRI feature measurements. A. functional tumor volume (FTV). Voxels with percentage enhancement (PE)  70% within the volume-of-interest shown as the yellow rectangular frame are counted in the FTV calculation. Color represents different levels of signal enhancement ratio (red: SER > 1.1; green: 0.9  SER  1.1; blue: SER < 0.9). B. longest diameter (LD). C. sphericity (SPH). Voxels in color mark where tumor boundary is. D. background parenchymal enhancement (BPE). Yellow curve shows the whole breast segmentation and voxels in blue shows the segmented fibroglandular tissue within the breast. BPE is calculated as the average PE among all blue voxels.